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Progressive multifocal leukoencephalopathy (PML) is a
demyelinating disease of the CNS caused by the JC virus.
It occurs in immunosuppressed individuals: patients with
AIDS, malignancies, autoimmune rheumatological dis-
eases, or those receiving immune therapy with monoclonal
antibodies.
Two patients diagnosed at 13 years old with HIV
infection, treated with combined active antiretroviral
therapy (cART) but with curling adherence in the last
years, were diagnosed after 2, respectively 3 years of
stopping therapy with PML. Both patients were with a
poor immunological status expressed by a low CD4 T-
cell count (<50 cells/µL) and high viral load (427,000
copies/mL) at the moment of diagnosis. They presented
headache, mild disturbances of fine movements and
mild speech disorders without fever, which constantly
progressed to hemiparesis, ataxia, dysarthria, aphasia,
visual disturbances and swallowing disorders. The cere-
brospinal fluid (CSF) was normal, the serology for Cryp-
tococcus, Herpes simplex virus, Varicella-Zoster virus,
Cytomegalovirus, Epstein Barr virus, Toxoplasma and
Treponema pallidum were negative, the cultures for
Mycobacterium tuberculosis, bacteria and fungi were
negative. MRI scan revealed diffuse lesions in the right
cerebellar hemisphere associated with edematous and
inflammatory cortico-subcortical lesions located in the
right fronto-parietal area with bilateral cerebellar exten-
sion and involvement of the pons after one month, in
one patient. The other patient presented diffuse lesions
located in the fronto-parietal periventricular white matter
and corpus callosum. There was no mass effect. On T2-
weighted and fluid-attenuated inversion recovery (FLAIR)
sequences, the lesions were hyperintense. Polymerase
chain reaction (PCR) for JC virus DNA in the CSF was
positive for one patient and negative for the other.
However, a negative PCR does not exclude this diagnosis.
Under cART one patient survived with some neurological
disorders, more than 5 years and today is a compliant,
undetectable patient; unfortunately the other patient died
after 3 months.
For both patients the diagnosis was sustained by the
clinical, biological findings and neuroimaging changes
on MRI, but only one was confirmed by the JC virus
DNA detected in the CSF.
In such cases antiretroviral therapy should be started
immediately, in order to achieve a rapid undetectable
HIV viral load.
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